Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
About 12,000 people starting GLP-1 drugs were compared against roughly 15,200 starting SGLT-2 inhibitors, and a separate group of about 12,000 GLP-1 starters was compared against 11,233 starting DPP-4 inhibitors
To counteract potential protopathic or ascertainment bias, any instances of primary and secondary outcomes that manifested before the designated index date were disregarded, prompting a repeat of the PSM process
Discover BPC-157 protocols for ankle injuries including Achilles tendinopathy, sprains & chronic instability
Fullen DR, Poynter JN, Lowe L, et al
US$ 26.99
US$ 20.45
,aspect=ignore)
US$ 28.81
US$ 22.71
US$ 22.18
US$ 24.71
